Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Iovance Biotherapeutics Inc. (IOVA)

11.05   0.21 (1.94%) 04-22 16:00
Open: 10.75 Pre. Close: 10.84
High: 11.285 Low: 10.58
Volume: 602,839 Market Cap: 1365M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.295 - 11.34 11.34 - 11.384
Low: 10.471 - 10.52 10.52 - 10.566
Close: 10.97 - 11.048 11.048 - 11.123

Technical analysis

as of: 2019-04-22 4:27:15 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.49     One year: 15.17
Support: Support1: 9.21    Support2: 7.66
Resistance: Resistance1: 11.55    Resistance2: 12.99
Pivot: 11.31
Moving Average: MA(5): 11.02     MA(20): 10.85
MA(100): 9.83     MA(250): 11.84
MACD: MACD(12,26): 0.26     Signal(9): 0.33
Stochastic oscillator: %K(14,3): 41.40     %D(3): 44.99
RSI: RSI(14): 52.64
52-week: High: 18.25  Low: 7.26  Change(%): -23.8
Average Vol(K): 3-Month: 104118  10-Days: 98813

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
IOVA has closed above bottom band by 41.7%. Bollinger Bands are 46.8% wider than normal. The large width of the bands suggest high volatility as compared to IOVA's normal range. The bands have been in this wide range for 11 bars. This is a sign that the current trend might continue.

Headline News

Wed, 03 Apr 2019 23:00:32 Z
Here's Why Iovance Biotherapeutics Soared on Wednesday

Wed, 03 Apr 2019 21:58:25 Z
Iovance Biotherapeutics (IOVA) Shares Cross Above 200 DMA

Thu, 28 Feb 2019 03:08:59 Z
Iovance Biotherapeutics, Inc. (IOVA) Q4 2018 Earnings Conference Call Transcript

Thu, 20 Dec 2018 20:08:23 Z
New 52-Week Low Could Prompt More Insider Buying At IOVA

Mon, 10 Dec 2018 16:36:25 Z
Monday 12/10 Insider Buying Report: IOVA, UAL

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 123.42
Shares Float (M) 102.40
% Held by Insiders 23.50
% Held by Institutions 124.70
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -1.280
EPS Est. Current Year -1.420
EPS Est. Next Year -1.440
EPS Est. Next Quarter
Forward EPS -1.320
Book Value (p.s.) 3.060
PEG Ratio 0.51
Profit Margin
Operating Margin
Return on Assets (ttm) -38.8
Return on Equity (ttm) -40.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -101.25
Levered Free Cash Flow (M) -58.43

Stock Valuations

P/E -8.63
P/E Growth Ratio 0.02
P/BV 3.61
P/CF -13.47

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2013-09-26
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.